{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:15:12Z","timestamp":1774314912565,"version":"3.50.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Diagnosing <jats:italic>Aspergillus<\/jats:italic> infections in patients with chronic pulmonary diseases is challenging, particularly in settings where invasive diagnostic tools are limited. This study explores a non-invasive diagnostic approach, combining serological tests and high-resolution computed tomography (HRCT) imaging, to identify patients who may need further invasive evaluation for <jats:italic>Aspergillus<\/jats:italic> infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study included patients with chronic pulmonary diseases from regional centers who experienced acute exacerbations that did not respond to antibacterial therapy, had positive sputum cultures for <jats:italic>Aspergillus<\/jats:italic> species, and lacked typical invasive radiological features on HRCT. Patients were classified based on clinical data, HRCT imaging, and serological markers (IgG, IgM, galactomannan) to distinguish between <jats:italic>Aspergillus<\/jats:italic> colonization and clinically diagnosed active infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 2,731 patients assessed, 209 met the study criteria: 112 were identified with <jats:italic>Aspergillus<\/jats:italic> colonization, and 97 with clinically diagnosed <jats:italic>Aspergillus<\/jats:italic> infection. Patients with active infection had significantly higher <jats:italic>Aspergillus<\/jats:italic> -specific IgG levels (median 185.47 IU\/mL vs. 59.96 IU\/mL, <jats:italic>p<\/jats:italic>&amp;lt;0.001) and higher galactomannan indices, especially those with invasive infection (<jats:italic>p<\/jats:italic>&amp;lt;0.001). HRCT scores were strongly correlated with the risk of infection. The combination of IgG levels and HRCT scores achieved an AUC (area under the curve) of 0.9 for differentiating infection from colonization and 0.74 for distinguishing different types of <jats:italic>Aspergillus<\/jats:italic> infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study supports the use of a non-invasive diagnostic approach, combining serological testing and HRCT imaging, to identify patients with chronic lung diseases who have positive sputum cultures for <jats:italic>Aspergillus<\/jats:italic> and are highly suspected of active infection, such as invasive pulmonary aspergillosis and chronic pulmonary aspergillosis, for further invasive diagnostic evaluation. This method is particularly useful in patients who experience frequent acute exacerbations and are unwilling or unable to undergo invasive diagnostic procedures, helping clinicians identify those who really require further definitive evaluation and thereby reducing unnecessary antifungal treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:uri>https:\/\/www.clinicaltrials.gov<\/jats:uri>, identifier NCT06379568.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1494522","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:31:34Z","timestamp":1751002294000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-invasive monitoring of Aspergillus infections in chronic lung disease patients: a combined serology and HRCT imaging approach"],"prefix":"10.3389","volume":"15","author":[{"given":"Rong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"021","DOI":"10.1055\/s-0043-1776777","article-title":"Microbiological diagnosis of pulmonary Aspergillus infections","volume":"45","author":"Aerts","year":"2024","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.10216.1","article-title":"Challenges in microbiological diagnosis of invasive Aspergillus infections","volume":"6","author":"Alanio","year":"2017","journal-title":"F1000Research"},{"key":"B3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1183\/09031936.00062206","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"30","author":"Bulpa","year":"2007","journal-title":"Eur. Respir. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1183","DOI":"10.1016\/S2214-109X(23)00217-6","article-title":"The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: A health-augmented macroeconomic modelling study","volume":"11","author":"Chen","year":"2023","journal-title":"Lancet Global Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/13993003.01216-2015","article-title":"Chronic pulmonary aspergillosis: Rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur. Respir. J."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2022.101310","article-title":"Trends in the prevalence of amphotericin B-resistance (AmBR) among clinical isolates of aspergillus species","volume":"32","author":"Fakhim","year":"2022","journal-title":"J. mycologie medicale"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1093\/jac\/dkv177","article-title":"High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients","volume":"70","author":"Fuhren","year":"2015","journal-title":"J. Antimicrobial Chemotherapy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1164\/rccm.201906-1185ST","article-title":"Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice","volume":"200","author":"Hage","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12890-020-01259-8","article-title":"The global impact of Aspergillus infection on COPD","volume":"20","author":"Hammond","year":"2020","journal-title":"BMC Pulmonary Med."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2016.PA555","article-title":"Aspergillus in COPD patients; is it a predictor for mortality","volume":"48","author":"Imming","year":"2016","journal-title":"Eur. Respir. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/17476348.2020.1753506","article-title":"Advances in the diagnosis of fungal pneumonias","volume":"14","author":"Kelly","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"B14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJM200008243430818","article-title":"Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone","volume":"343","author":"Leav","year":"2000","journal-title":"New Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-15-10","article-title":"High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis","volume":"15","author":"Oda","year":"2014","journal-title":"Respir. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s15010-022-01960-2","article-title":"The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease","volume":"51","author":"Otu","year":"2023","journal-title":"Infection"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.5772\/20965","volume-title":"High resolution computed tomography and chronic obstructive pulmonary disease","author":"Parkash","year":"2011"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/ffunb.2022.996574","article-title":"Breathing can be dangerous: Opportunistic fungal pathogens and the diverse community of the small mammal lung mycobiome","volume":"3","author":"Salazar-Hamm","year":"2022","journal-title":"Front. Fungal Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.2147\/IDR.S460513","article-title":"Value evaluation of quantitative aspergillus fumigatus-specific igG antibody test in the diagnosis of non-neutropenic invasive pulmonary aspergillosis","volume":"17","author":"Sheng","year":"2024","journal-title":"Infection Drug resistance"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2002050","DOI":"10.1183\/13993003.02050-2020","article-title":"A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD","volume":"57","author":"Tiew","year":"2021","journal-title":"Eur. Respir. J."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.640289","article-title":"Respiratory Aspergillus colonization was associated with relapse of acute exacerbation in patients with chronic obstructive pulmonary disease: Analysis of data from a retrospective cohort study","volume":"8","author":"Wu","year":"2021","journal-title":"Front. Med. (Lausanne)"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1494522\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:31:35Z","timestamp":1751002295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1494522\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":21,"alternative-id":["10.3389\/fcimb.2025.1494522"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1494522","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"article-number":"1494522"}}